Company intelligence / Profile preview

BioBioPha

Kunming, Yunnan, China

Ownership: Private
Development stage: Other

Overview

BioBioPha operates a large-scale, proprietary natural product compound library (over 10,000 compounds, ~15% novel) sourced from medicinal plants, fungus, and microbes, enabling drug discovery efforts but does not have clinical-stage assets itself[1][2].

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Over 1,500 partners globally including pharma, biotech, academic, and research institutions[4]

Beyond the preview

Go deeper on BioBioPha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioBioPha.

Explore the full profile